Oramed Pharmaceuticals ORMP Growth Metrics (2009-2026)

NASDAQ ORMP
$3.97 -0.03 (-0.75%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Oramed Pharmaceuticals Quarterly Growth Metrics

Periods 68 quarters
Latest Jun 2026

Oramed Pharmaceuticals reported asset growth of 33.23% for the quarter ended Jun 2026. These growth metrics cover 68 quarters of results from May 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth May2009 Aug2009 Nov2009 Feb2010 May2010 Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ)
-33.33%11,531.03%-37.79%-98.65%6,900.00%-98.57%0.00%200.00%835,845,333.33%-99.79%36,856.84%160.35%0.00%-100.00%-95.55%6,944,438.89%0.00%-99.97%14,347.85%-91.85%
Total Debt Growth (5y)
20.23%4.29%
Total Debt Growth (3y)
8.83%427.35%334.97%-21.35%13,472.15%3,193.17%767.13%4,450.06%1,267.68%
Total Debt Growth (1y)
16.00%7,395.56%4,412.90%-98.65%200.00%35,821,847.14%5,149,700.00%1,903,203,300.00%1,651,666,566.67%97.60%-98.43%-100.00%-94.95%-94.95%-19.41%261,566.67%-99.69%
Tax Rate (QoQ)
55.00
Tax Rate Growth (1y)
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-53.29%62.06%-16.46%-93.21%952.02%-53.19%60.45%-5.34%-5.02%-75.51%308.31%78.11%-63.45%-10.12%217.66%-23.99%-19.76%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
61.02%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
92.69%-18.40%-24.81%-38.23%-3.58%115.69%-8.53%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
439.43%-95.71%-3.29%-72.07%-46.35%647.98%-32.47%-64.67%-10.10%69.17%-34.91%138.87%85.84%-20.69%74.13%
Revenue (QoQ)
2.41%1.20%1.19%32.55%-26.33%1.20%
Revenue Growth (5y)
33.10%
Revenue Growth (3y)
3.34%44.27%
Revenue Growth (1y)
0.00%0.00%0.00%
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.02M-443.000.05M-0.02M0.06M0.02M-0.05M-0.01M-0.05M0.00M-0.01M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.04M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.16M0.15M0.10M0.06M0.06M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.06M0.09M0.11M0.01M0.02M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
0.00M2.00-4.00-996.00903.0060.00-50.00-358.0095.00
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
0.00M0.00M
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
-94.00-37.00-83.00555.00-253.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-834.000.00M-258.000.00M-152.000.00M444.00645.00255.000.00M294.00590.00-948.000.00M-713.00332.000.00M722.000.00M0.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
645.000.00M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M0.00M0.00M-422.000.00M0.01M0.01M0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
899.00-808.000.00M0.00M-396.0012.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-487.00-984.00-926.000.00M361.00505.00-218.000.00M157.0081.00-95.00-56.00-154.0075.00203.00-27.00135.00125.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.01M0.00M-378.00750.000.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M0.00M-645.000.00M0.00M0.00M0.00M87.00-224.00-230.0068.0097.00386.00435.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-381.000.00M-200.000.00M-136.000.00M405.00581.00489.000.00M258.00589.00-816.000.00M-675.00301.000.00M544.000.00M0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
492.000.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-830.000.00M0.00M0.00M-409.000.00M0.01M0.01M0.01M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M-422.000.00M0.00M-388.00237.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-6.27%2.06%-3.02%1.18%24.71%52.34%19.88%-3.28%-2.33%-5.42%-6.19%-6.59%-6.14%-2.79%-3.87%-3.87%-4.81%-4.56%-4.27%-5.17%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
87.03%90.08%91.37%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
183.90%185.83%155.81%16.53%14.56%4.70%-10.41%-16.88%-17.43%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
1,668.18%301.01%-5.87%130.42%120.28%72.52%7.12%-16.17%-19.05%-22.21%-20.05%-18.07%-15.69%-14.48%-16.05%-16.39%-17.52%
Operating Margin (QoQ)
0.02M-443.000.05M-0.02M0.06M0.02M
Operating Margin Growth (5y)
-0.04M
Operating Margin Growth (3y)
0.16M0.15M
Operating Margin Growth (1y)
0.06M0.09M0.11M
Operating Income (QoQ)Op. Inc (QoQ)
25.68%-1.47%28.27%-50.52%57.75%27.21%23.69%-34.01%23.60%-5.84%1.47%-16.38%-25.17%44.69%2.49%-133.70%35.49%24.41%
Operating Income Growth (5y)Op. Inc Growth (5y)
23.73%39.91%
Operating Income Growth (3y)Op. Inc Growth (3y)
49.62%55.18%26.32%39.81%33.33%22.80%11.10%9.97%
Operating Income Growth (1y)Op. Inc Growth (1y)
169.04%38.32%53.71%66.80%64.67%68.55%43.13%17.30%-6.77%7.27%-51.92%20.61%21.43%-57.77%18.69%-11.13%
Net Margin (QoQ)
0.01M256.000.05M-0.03M0.08M0.03M
Net Margin Growth (5y)
-0.05M
Net Margin Growth (3y)
0.15M0.12M
Net Margin Growth (1y)
0.04M0.11M0.14M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
13.00%-205.26%243.95%-1.04%32.97%-65.27%70.90%64.83%-169.85%500.34%-88.09%499.74%-312.97%48.07%25.00%273.88%264.20%-79.32%282.76%104.01%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
21.14%20.42%37.94%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
47.30%-23.27%56.51%9.83%48.30%106.88%41.91%136.83%307.08%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
127.98%-282.94%41.65%67.43%88.66%54.36%210.55%145.24%871.52%-508.91%-178.99%-597.53%44.25%346.67%198.23%601.31%488.17%
Net Income (QoQ)
-22.07%2.56%-47.75%-3.35%34.46%-68.96%70.53%63.64%-150.11%518.18%-88.83%500.00%-313.41%48.08%25.07%273.51%264.92%-79.32%282.76%104.01%
Net Income Growth (5y)
-36.95%20.42%-25.17%
Net Income Growth (3y)
-8.91%-23.27%-23.47%10.64%47.33%105.45%41.23%132.75%294.78%
Net Income Growth (1y)
-146.28%-82.94%-45.39%66.28%88.14%54.72%212.06%142.48%800.99%-498.11%-174.27%-598.17%44.07%346.35%198.14%601.31%489.41%
Net Cash Flow (QoQ)NCF (QoQ)
255.89%76.34%123.36%-321.38%-6.26%92.69%382.26%166.05%595.03%-164.45%128.88%63.15%-390.53%162.30%-116.93%-432.02%106.60%
Net Cash Flow Growth (5y)NCF Growth (5y)
-94.80%
Net Cash Flow Growth (3y)NCF Growth (3y)
-241.86%236.81%-221.37%122.53%-41.54%-26.15%28.56%
Net Cash Flow Growth (1y)NCF Growth (1y)
-939.34%-3,203.04%-1,026.50%-138.41%-51.46%158.34%481.58%-3,263.72%244.17%111.06%-188.22%185.29%-150.00%-263.04%103.70%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
8.59%-56.28%-140.07%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
19.73%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
27.64%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-90.52%97.74%
Income After Tax (QoQ)
22.07%-3.35%34.46%-68.96%70.53%63.64%-150.11%504.87%-88.46%500.00%-313.41%48.08%25.07%273.51%264.92%-79.32%282.76%104.01%
Income After Tax Growth (5y)
23.02%37.92%
Income After Tax Growth (3y)
48.76%54.62%10.64%47.33%105.45%41.23%132.75%294.78%
Income After Tax Growth (1y)
146.28%35.60%66.28%88.14%54.72%208.49%142.48%800.99%-498.11%-176.71%-598.17%44.07%346.35%198.14%601.31%489.41%
Gross Profit (QoQ)
Gross Profit Growth (3y)
Gross Profit Growth (1y)
Gross Margin (QoQ)
Gross Margin Growth (3y)
Gross Margin Growth (1y)
Free Cash Flow (QoQ)FCF (QoQ)
7.22%72.24%-254.36%31.33%53.83%72.65%-95.73%-4.01%240.46%-442.29%72.95%-83.25%-0.48%54.08%71.20%-523.93%93.08%
Free Cash Flow Growth (5y)FCF Growth (5y)
-45.89%
Free Cash Flow Growth (3y)FCF Growth (3y)
-18.59%27.32%25.36%11.72%61.76%20.21%57.62%
Free Cash Flow Growth (1y)FCF Growth (1y)
-6.77%37.33%68.81%69.26%83.02%74.29%178.22%-878.79%-35.26%-138.29%-270.47%77.13%75.65%17.09%94.29%
FCF Margin (QoQ)
0.01M0.09M-0.06M0.01M0.05M
FCF Margin Growth (5y)
FCF Margin Growth (3y)
0.12M
FCF Margin Growth (1y)
0.05M0.09M
EPS (Diluted) (QoQ)
13.00%-118.58%218.65%-0.73%33.50%-65.70%71.66%64.99%-168.38%499.15%-88.38%499.35%-316.59%47.98%25.73%268.25%262.80%-79.14%286.85%101.46%
EPS (Diluted) Growth (5y)
7.30%50.40%17.23%
EPS (Diluted) Growth (3y)
32.96%50.23%28.05%11.73%46.57%102.19%40.76%133.71%299.90%
EPS (Diluted) Growth (1y)
135.62%-132.30%-79.39%68.54%89.07%55.88%206.27%143.59%846.20%-502.19%-178.48%-601.57%40.80%335.85%194.55%592.45%489.67%
EPS (Basic) (QoQ)
1.95%-210.66%211.75%-0.73%33.50%-65.70%71.66%64.99%-168.38%501.64%-88.24%497.93%-313.30%47.98%25.73%271.74%264.09%-79.14%288.66%102.68%
EPS (Basic) Growth (5y)
2.72%32.36%25.21%
EPS (Basic) Growth (3y)
37.16%0.70%42.15%11.73%46.94%103.43%41.08%135.62%304.45%
EPS (Basic) Growth (1y)
76.83%-231.94%-8.28%68.54%89.07%55.88%206.94%144.36%857.70%-502.19%-178.00%-592.79%41.54%341.60%196.87%606.90%498.24%
EBT (QoQ)
22.07%-3.35%35.37%-71.33%70.53%63.64%-150.11%504.87%-88.46%606.52%-270.78%47.14%27.85%286.09%352.65%-83.52%404.64%105.48%
EBT Margin (QoQ)
0.01M0.00M0.06M-0.03M0.08M0.03M
EBT Margin Growth (5y)
-0.04M
EBT Margin Growth (3y)
0.15M0.13M
EBT Margin Growth (1y)
0.05M0.11M0.14M
EBT Growth (5y)
23.02%40.76%
EBT Growth (3y)
48.76%54.62%12.97%47.16%117.66%40.94%150.35%329.75%
EBT Growth (1y)
146.28%35.60%66.28%88.14%54.09%208.49%142.48%925.44%-463.61%-173.58%-560.10%21.18%421.20%200.14%800.48%673.47%
EBIT (QoQ)
25.68%-1.47%28.27%-50.52%57.75%27.21%23.69%-34.01%23.60%-5.84%1.47%-16.38%-25.17%44.69%2.49%-133.70%35.49%24.41%
EBIT Margin (QoQ)
0.02M-443.000.05M-0.02M0.06M0.02M
EBIT Margin Growth (5y)
-0.04M
EBIT Margin Growth (3y)
0.16M0.15M
EBIT Margin Growth (1y)
0.06M0.09M0.11M
EBIT Growth (5y)
23.73%39.91%
EBIT Growth (3y)
49.62%55.18%26.32%39.81%33.33%22.80%11.10%9.97%
EBIT Growth (1y)
169.04%38.32%53.71%66.80%64.67%68.55%43.13%17.30%-6.77%7.27%-51.92%20.61%21.43%-57.77%18.69%-11.13%
EBITDA Margin (QoQ)
-385.000.05M-0.02M0.06M0.02M
EBITDA Margin Growth (5y)
EBITDA Margin Growth (3y)
0.15M
EBITDA Margin Growth (1y)
0.09M0.11M
Dividends payables (QoQ)
-97.14%-12.87%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
6.96%73.60%-259.75%31.17%52.53%73.65%-104.32%-4.09%240.65%-442.05%73.09%-84.14%-0.45%54.03%71.32%-525.54%93.14%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-45.89%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-18.67%27.21%25.33%10.16%61.34%19.31%57.65%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-12.21%39.19%68.98%69.03%82.41%73.40%178.82%-923.20%-34.77%-138.41%-270.28%77.12%75.61%17.16%94.34%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
40.82%-88.14%816.19%-217.26%-11.41%-410.69%139.93%0.00%215.54%-136.19%145.02%53.11%-332.27%169.94%-104.39%-1,057.24%122.12%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-95.87%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-227.33%47.50%-93.93%214.86%-29.06%-13.86%31.87%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-8,360.88%-279.41%-241.95%-6,212.45%166.40%327.21%743.47%54.39%-48.58%-21.27%-157.95%211.98%-110.92%-182.52%107.86%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
69.84%34.54%-58.73%6.88%11.05%21.89%-40.43%-71.93%-19.20%65.60%105.15%356.25%-50.32%29.25%36.93%-78.80%230.31%-11.94%-71.27%15.47%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
77.03%81.64%69.33%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
150.03%149.12%102.12%38.63%-19.15%16.27%4.33%-18.18%31.09%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
516.49%300.32%113.52%-13.81%-77.36%-83.53%-77.62%-22.93%1,152.45%670.01%500.99%301.14%-81.36%23.93%-15.57%-82.28%-3.49%
Capital Expenditures (QoQ)Capex (QoQ)
-57.45%505.00%154.55%-35.39%-89.95%60.00%-90.63%-33.33%120.00%-72.73%33.33%150.00%-60.00%
Capital Expenditures Growth (5y)Capex Growth (5y)
Capital Expenditures Growth (3y)Capex Growth (3y)
-60.04%-41.52%-81.34%-70.71%-53.58%
Capital Expenditures Growth (1y)Capex Growth (1y)
323.40%0.00%-73.55%-99.03%-98.99%-84.38%266.67%50.00%-81.82%66.67%-50.00%
Assets (QoQ)
30.55%59.02%42.54%-5.77%1.32%-1.70%-1.15%-2.17%47.71%-4.48%-7.66%-9.54%-10.39%-5.94%-4.98%9.59%36.37%4.70%16.45%37.49%
Assets Growth (5y)
17.26%24.48%32.35%
Assets Growth (3y)
32.43%39.26%61.15%-5.03%-0.12%10.27%12.62%18.94%33.23%
Assets Growth (1y)
74.39%186.78%345.31%-7.23%-3.68%40.41%36.44%27.46%17.85%-28.50%-29.60%-27.55%-12.23%33.57%48.68%82.22%128.62%

Oramed Pharmaceuticals Growth Metrics API

Pull Oramed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ORMP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY